<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Invest in Cancer Research</title>
    <meta content="l24cancer" name="slug"/>
    <meta content="24" name="publication_day_of_month"/>
    <meta content="1" name="publication_month"/>
    <meta content="2007" name="publication_year"/>
    <meta content="Wednesday" name="publication_day_of_week"/>
    <meta content="Editorial Desk" name="dsk"/>
    <meta content="20" name="print_page_number"/>
    <meta content="A" name="print_section"/>
    <meta content="4" name="print_column"/>
    <meta content="Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1821047"/>
      <doc.copyright holder="The New York Times" year="2007"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Cancer</classifier>
        <classifier class="indexing_service" type="descriptor">Research</classifier>
        <org class="indexing_service">Leukemia and Lymphoma Society</org>
        <person class="indexing_service">Howell, Dwayne</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion/Letters</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Cancer</classifier>
        <classifier class="online_producer" type="general_descriptor">Research</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20070124T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9E0CE5DE163FF937A15752C0A9619C8B63" item-length="176" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Invest in Cancer Research</hl1>
      </hedline>
      <abstract>
        <p>Letter from Dwayne Howell (Leukemia and Lymphoma Society) says investment in cancer research must continue despite drop in cancer deaths (Jan 18 article)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Re ''Second Drop in Cancer Deaths Could Point to a Trend, Researchers Say'' (news article, Jan. 18):</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Re ''Second Drop in Cancer Deaths Could Point to a Trend, Researchers Say'' (news article, Jan. 18):</p>
        <p>News that cancer deaths have dropped for the second year is certain to be met with great optimism.</p>
        <p>Early detection, improved treatments and actions taken to prevent getting cancer in the first place have clearly had a significant effect. But this news is not reason to become complacent in the face of a scourge that kills more than half a million people in the United States each year.</p>
        <p>We must remain mindful that there are many cancers that are not prevented by changes in behavior or lifestyle. And while encouraging advances are being made all the time, five-year survival rates for some cancers are still abysmal, and these diseases require a greater investment in research.</p>
        <p>Cuts in money for research are already jeopardizing potentially lifesaving programs. Investing in cancer research must remain the nation's highest priority until cures are found.</p>
        <p>Dwayne Howell  President and C.E.O.  Leukemia &amp; Lymphoma Society  White Plains, Jan. 22, 2007</p>
      </block>
    </body.content>
  </body>
</nitf>
